Page 10 - FLIPBOOK

ADT is Foundational in the Treatment of Advanced

Prostate Cancer

• Prostate cancer is primarily

androgen dependent

• Primary ligand is T

MED
• Goal is to lower and maintain T

to castrate levels and/or block

activity at AR

• Maximally deprive tumour LOW HIGH

environment of T Testosterone Levels

• There is a range of therapeutic

options for effective ADT

Crawford ED, et al. Prostate Cancer Prostatic Dis 2019;22:24–38